Nanopeptide Biotechnology

China-based EOC Pharma Group has announced a strategic partnership with fellow country siRNA firm, Nanopeptide (Qingdao) Biotechnology Ltd., to delve into the research and development of small nucleic acid drugs within the cardiovascular field. Agreement Terms and Regional RightsUnder the terms of the agreement, Nanopeptide has granted EOC Pharma Group…